{{Rsnum
|rsid=641101
|Gene=FGFR4
|Chromosome=5
|position=177086459
|Orientation=plus
|GMAF=0.303
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=FGFR4
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 12.4 | 42.5 | 45.1
| HCB | 0.0 | 5.1 | 94.9
| JPT | 0.0 | 1.8 | 98.2
| YRI | 39.5 | 48.3 | 12.2
| ASW | 33.3 | 47.4 | 19.3
| CHB | 0.0 | 5.1 | 94.9
| CHD | 0.0 | 9.2 | 90.8
| GIH | 2.0 | 24.8 | 73.3
| LWK | 33.6 | 52.7 | 13.6
| MEX | 1.7 | 34.5 | 63.8
| MKK | 28.8 | 44.9 | 26.3
| TSI | 12.7 | 54.9 | 32.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=21656577
|Title=Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma
}}

{{PMID|22313031|OA=1
}} Fibroblast growth factor receptor 4 polymorphisms and susceptibility to coronary artery disease.

{{on chip | Illumina Human 1M}}